← Back to Clinical Trials
Recruiting NCT06521918

NCT06521918 Combined Artificial Intelligence and Mobile Application for Remote Infant Motor Screening: Development and Validation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06521918
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Motor Disorders
Study Type OBSERVATIONAL
Enrollment 242 participants
Start Date 2024-10-17
Primary Completion 2027-07-31

Trial Parameters

Condition Motor Disorders
Sponsor National Taiwan University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 242
Sex ALL
Min Age 2 Months
Max Age 18 Months
Start Date 2024-10-17
Completion 2027-07-31

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is therefore five-fold: (1) designation of an APP "Baby Go" version 3.0 to include the assessment, follow-up, and education functions for parental use at home, (2) development and validation of the AI algorithm for infant motor assessment based on home videos obtained from term and preterm infants, (3) comparison of parental perception and report with AI-driven assessment results, (4) examination of the predictive validity of the AI algorithm for infant motor assessment on subsequent outcome, and (5) investigation of the usability of the APP "Baby Go" version 3.0 in parents and clinicians.

Eligibility Criteria

The inclusion criterion is: Preterm infants: gestational age \< 37 weeks, birth body weight \< 2,500 grams, and corrected age of 2-18 months. Term infants: gestational age 37-42 weeks, birth body weight \>2,500 grams, and age of 2-18 months. Clinicians: who provide early intervention to the participating infants in this study. The exclusion criterion is: Infants: parents can not read Chinese. Clinicians: can not read Chinese

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology